Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 30 Apr 2026 Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination npj Antimicrobials and Resistance
In the media 29 Apr 2026 ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด Thai Rath
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 25 Apr 2026 ‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África Alma Preta
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Scientific articles 14 Apr 2026 Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis Clinical and Translational Science
Press releases 5 Jun 2025 Colombia becomes first country to recommend rapid tests to diagnose Chagas disease
Press releases 22 May 2025 Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis
Press releases 13 May 2025 First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Press releases 15 Apr 2025 New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease
Press releases 18 Mar 2025 DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease
Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team
Press releases 10 Feb 2025 The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative
Press releases 4 Feb 2025 Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment
Press releases 30 Jan 2025 DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease
Press releases 30 Jan 2025 IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
